2024 ACA National Harbor Program Book_Winter Conference

practices in a correctional setting based on national standards of practice; 9) The medical management of overdose and withdrawal in a correctional setting. Learning Objectives: • Types of medications used for medication for opioid use disorder (MOUD). • Special considerations for use of medications for opioid use disorder in a correctional setting to include diversion and misuse. • Considerations when developing medical guidelines and practices in a correctional setting based on national standards of practice. Moderator: Stephen M. Herrick , MSHA, Ph.D., Director of Health Services, Virginia Department of Corrections, Richmond, Virginia Speaker: Trey Fuller , PharmD, Chief Pharmacist, Virginia Department of Corrections, Richmond, Virginia; Stephen M. Herrick , MSHA, Ph.D., Director of Health Services, Virginia Department of Corrections, Richmond, Virginia; Paul V. Targonski , M.D., Ph.D., Chief Medical Officer, Virginia Department of Corrections, Richmond, Virginia

team as we host a panel of senior leaders from Maryland, who will share how the state’s response mitigated the spread of the virus, saved lives, saved more than $3 million in medical expenses and how that approach is being used to support other correctional health needs and emergency planning. Learning Objectives: • Explore the value of partnerships across State agencies to support corrections. • Learn about Maryland’s Alternative Care Sites and the state’s successful nine-layered mitigation approach to COVID-19. • Hear from Emergency Managers about future pandemic planning and how COVID-19 has prepared us for the next event. Moderators: Robert Fletcher , Senior Emergency Management Consultant, CDMCF TTA Team, Edgewater, Maryland; Sara Sullivan , Senior Policy Advisor, Bureau of Justice Assistance, Washington, D.C. Speakers: Dr. Cliff Mitchell , Senior Clinical Advisor, Maryland Department of Health, Baltimore, Maryland; Carolyn J. Scruggs , Secretary, Maryland Department of Public Safety and Correctional Services, Baltimore, Maryland; Russ Strickland , Secretary, Maryland Department of Emergency Management, Reisterstown, Maryland A-3N Medication for Opioid Use Disorder (MOUD) Panel Discussion (CE) Track: Healthcare & Treatment Room: National Harbor 15 This panel will present the use of Medications for Opioid Use Disorder (MOUD) in a correctional setting. Topics will include; 1) Data opioid use disorder (OUD); 2) General estimates of mortality and morbidity of OUD; 3) a brief description of OUD: 4) types of medications used for MOUD; 5) coverage by the American with Disabilities Act; 6) special considerations for use of these medications in a correctional setting to include diversion and misuse; 7) the pros and cons of using long acting injectables as an option; 8) considerations when developing medical guidelines and

WORKSHOPS

Thursday, Jan. 4 ▼ 2–3:30 p.m.

ACA 2024 Winter Conference | National Harbor, MD — 93